Screening laboratory evaluation in psychiatric patients: a review

Standard lab screening in psychiatric settings is widely practiced. Prior research has shown limited benefits and higher costs for general medical screening in non-psychiatric patients. This gap motivated a review of screening practices specifically for psychiatric populations. Established knowledge includes the high rate of clinically insignificant findings in routine screening. No prior work had resolved which psychiatric subgroups might benefit from extended testing. This paper's contribution is a synthesis of evidence on screening utility in psychiatric patients. The review highlights how most abnormal results do not change clinical management. It also identifies specific patient characteristics that may justify more extensive testing.

This review aimed to evaluate the clinical and economic value of routine laboratory screening in psychiatric patients. The specific problem is the lack of evidence supporting widespread use of extensive screening batteries. The motivation is to guide clinical decision-making in psychiatric settings. The study sought to distinguish between necessary and unnecessary tests. It also aimed to identify patient subgroups where screening may be more beneficial. The authors wanted to assess whether current screening practices align with available evidence. They focused on determining which tests provide actionable information. The review also aimed to inform cost-effective diagnostic strategies.

The authors conducted a literature review of studies on laboratory screening in psychiatric patients. They analyzed data on the frequency and clinical relevance of abnormal findings. The review included studies on CBC, blood chemistry, ESR, and other tests. They compared outcomes in patients with and without extensive screening. The authors evaluated the predictive value of patient history and physical exams. They considered socioeconomic and age-related factors influencing test utility. The review also examined the impact of psychotropic medications on test results. The authors synthesized findings to identify patterns in test usefulness.

The review found that most abnormal lab results in psychiatric patients are clinically insignificant. Routine extensive screening does not improve patient management or outcomes. Serum glucose, BUN, creatinine, and urinalysis showed more consistent clinical relevance. Patients over 65 or with low socioeconomic status may benefit from broader testing. History and physical exams often predict abnormal findings more effectively. Psychotropic medications require monitoring for specific side effects. The review noted that most screening batteries yield non-actionable results. The authors suggest that targeted testing based on patient characteristics is preferable.

The authors propose that routine extensive screening is not indicated for most psychiatric patients. They suggest that targeted testing based on patient history and risk factors is more effective. The review supports limited use of serum glucose, BUN, creatinine, and urinalysis. The authors emphasize the need for cost-efficient diagnostic strategies. They note that certain subgroups may benefit from more extensive evaluation. The findings suggest that abnormal results often do not change clinical decisions. The authors recommend further prospective studies to refine screening protocols. They conclude that current practices may not align with available evidence.